RCSI launches Ireland’s first National Robotic Surgery Curriculum
RCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Read moreRCSI has launched Ireland’s first National Robotic Surgery Curriculum, supported by a €2.3m investment and designed to standardise robotic surgical training nationwide.
Read moreNordic Pharma has announced the European launch of Lacrifill®, a CE-marked canalicular gel designed to enhance tear film preservation in patients with dry eye disease.
Read moreIntroduction Refractive surgery encompasses a range of procedures designed to correct or minimize refractive errors such as myopia (nearsightedness), hyperopia
Read moreGlaucoma is the most common cause of irreversible blindness worldwide. Open-angle glaucoma (OAG) is the most frequent phenotype, with a
Read moreAge related macular degeneration (AMD) is the leading cause of sight loss in the over 50s in Ireland. More than
Read moreMacular oedema is the end common pathway for many prevalent ophthalmic conditions. It is one of the leading causes of
Read more[pdf-embedder url=”https://hospitalprofessionalnews.ie/wp-content/uploads/2021/10/Increasing-the-Visibility-of-Women-An-initiative-by-the-Women-in-Vision-and-Eye-Research-Ireland.pdf” title=”Increasing the Visibility of Women – An initiative by the Women in Vision and Eye Research Ireland”]
Read more[pdf-embedder url=”https://hospitalprofessionalnews.ie/wp-content/uploads/2020/11/Potential-new-treatment-for-severe-dry-eye-disease-RCSI.pdf” title=”Potential new treatment for severe dry eye disease, RCSI”]
Read more